People with severe mental illness often face years of poor health before diagnosis. A new study uses machine learning and clinical notes to map the early warning networks of symptoms that could help us intervene earlier.
[read the full story...]
KCL MSc student Geetika Sharma reviews a study that looks at the contribution of cannabis use to the increased psychosis risk among minority ethnic groups in Europe.
[read the full story...]
What happens to psychosis risk when cannabis becomes easier to access? According to this Canadian study, the risk goes up. Shuichi Suetani explores what we can learn from one of the countries leading the way in drug policy reform.
[read the full story...]
In her debut blog, Sally Turner considers a recent study on cannabis use and clinical outcomes in people with first-episode schizophrenia spectrum disorders over 24 months of treatment.
[read the full story...]
Ian Hamilton summarises a recent study exploring whether psychotic-like experiences are related to the discontinuation of cannabis consumption in young adults.
[read the full story...]
Ian Hamilton summarises the recently published CIRCLE trial, which looks at the clinical and cost-effectiveness of contingency management for cannabis use in early psychosis.
[read the full story...]
Luke Sheridan-Reins explores a recent paper on the contribution of cannabis use to variation in the incidence of psychotic disorder across Europe.
[read the full story...]
Suzi Gage summarises a recent GWAS of lifetime cannabis use, which reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia. Interesting new evidence ahead of our Mental Health Question Time #MHQT event in London tomorrow.
[read the full story...]
Luke Sheridan Rains publishes his debut blog on a recent multicentre RCT of Cannabidiol (CBD) as an adjunctive therapy for people with schizophrenia, which suggests that CBD had a beneficial, but modest impact on positive psychotic symptoms and severity of illness when used alongside existing antipsychotics.
[read the full story...]
James MacCabe appraises a recent study, which looks at the association of combined patterns of tobacco and cannabis use in adolescents who go on to experience psychotic symptoms.
[read the full story...]
